United States Drugs for Schistosomiasis Market by Manufacturers, States, Type and Application, Forecast to 2022

July 2017 | 120 pages | ID: UCA0F39B594EN
GlobalInfoResearch

Abstracts

Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.

Scope of the Report:

This report focuses on the Drugs for Schistosomiasis in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers

• Shin Poong
• Merck
• Bayer
• EIPICO
• Chandra Bhagat Pharma
• Taj Pharmaceuticals

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• Praziquantel
• Oxamniquine
• Other

Market Segment by Applications, can be divided into

• S. haematobium
• S. mansoni
• S. japonicum
• S. mekongi
• S. intercalatum

There are 17 Chapters to deeply display the United States Drugs for Schistosomiasis market.

Chapter 1, to describe Drugs for Schistosomiasis Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Schistosomiasis, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Drugs for Schistosomiasis, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Drugs for Schistosomiasis market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Drugs for Schistosomiasis Research Findings and Conclusion, Appendix, methodology and data source.

Contents

1 1 MARKET OVERVIEW

1.1 Drugs for Schistosomiasis Introduction
1.2 Market Analysis by Type
  1.2.1 Praziquantel
  1.2.2 Oxamniquine
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 S. haematobium
  1.3.2 S. mansoni
  1.3.3 S. japonicum
  1.3.4 S. mekongi
  1.3.5 S. intercalatum
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2012-2022)
  1.4.2 Texas Status and Prospect (2012-2022)
  1.4.3 New York Status and Prospect (2012-2022)
  1.4.4 Florida Status and Prospect (2012-2022)
  1.4.5 Illinois Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Shin Poong
  2.1.1 Profile
  2.1.2 Drugs for Schistosomiasis Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 Shin Poong News
2.2 Merck
  2.2.1 Profile
  2.2.2 Drugs for Schistosomiasis Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Merck News
2.3 Bayer
  2.3.1 Profile
  2.3.2 Drugs for Schistosomiasis Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Bayer News
2.4 EIPICO
  2.4.1 Profile
  2.4.2 Drugs for Schistosomiasis Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 EIPICO News
2.5 Chandra Bhagat Pharma
  2.5.1 Profile
  2.5.2 Drugs for Schistosomiasis Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Chandra Bhagat Pharma News
2.6 Taj Pharmaceuticals
  2.6.1 Profile
  2.6.2 Drugs for Schistosomiasis Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Taj Pharmaceuticals News

3 UNITED STATES DRUGS FOR SCHISTOSOMIASIS MARKET COMPETITION, BY MANUFACTURER

3.1 United States Drugs for Schistosomiasis Sales and Market Share by Manufacturer (2016-2017)
3.2 United States Drugs for Schistosomiasis Revenue and Market Share by Manufacturer (2016-2017)
3.3 United States Drugs for Schistosomiasis Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Drugs for Schistosomiasis Manufacturer Market Share
  3.4.2 Top 5 Drugs for Schistosomiasis Manufacturer Market Share
3.5 Market Competition Trend

4 UNITED STATES DRUGS FOR SCHISTOSOMIASIS MARKET ANALYSIS BY STATES

4.1 United States Drugs for Schistosomiasis Sales Market Share by States
4.2 United States Drugs for Schistosomiasis Sales by States (2012-2017)
4.3 United States Drugs for Schistosomiasis Revenue (Value) by States (2012-2017)

5 UNITED STATES MARKET SEGMENTATION DRUGS FOR SCHISTOSOMIASIS BY TYPE

5.1 United States Drugs for Schistosomiasis Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 United States Drugs for Schistosomiasis Sales and Market Share by Type (2012-2017)
  5.1.2 United States Drugs for Schistosomiasis Revenue and Market Share by Type (2012-2017)
5.2 Praziquantel Sales Growth and Price
  5.2.1 United States Praziquantel Sales Growth (2012-2017)
  5.2.2 United States Praziquantel Price (2012-2017)
5.3 Oxamniquine Sales Growth and Price
  5.3.1 United States Oxamniquine Sales Growth (2012-2017)
  5.3.2 United States Oxamniquine Price (2012-2017)
5.4 Other Sales Growth and Price
  5.4.1 United States Other Sales Growth (2012-2017)
  5.4.2 United States Other Price (2012-2017)

6 UNITED STATES MARKET SEGMENTATION DRUGS FOR SCHISTOSOMIASIS BY APPLICATION

6.1 United States Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
6.2 S. haematobium Sales Growth (2012-2017)
6.3 S. mansoni Sales Growth (2012-2017)
6.4 S. japonicum Sales Growth (2012-2017)
6.5 S. mekongi Sales Growth (2012-2017)
6.6 S. intercalatum Sales Growth (2012-2017)

7 CALIFORNIA DRUGS FOR SCHISTOSOMIASIS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
7.2 California Drugs for Schistosomiasis Sales and Market Share by Type
7.3 California Drugs for Schistosomiasis Sales by Application (2012-2017)

8 NEW YORK DRUGS FOR SCHISTOSOMIASIS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
8.2 New York Drugs for Schistosomiasis Sales and Market Share by Type
8.3 New York Drugs for Schistosomiasis Sales by Application (2012-2017)

9 TEXAS DRUGS FOR SCHISTOSOMIASIS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
9.2 Texas Drugs for Schistosomiasis Sales and Market Share by Type
9.3 Texas Drugs for Schistosomiasis Sales by Application (2012-2017)

10 FLORIDA DRUGS FOR SCHISTOSOMIASIS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
10.2 Florida Drugs for Schistosomiasis Sales and Market Share by Type
10.3 Florida Drugs for Schistosomiasis Sales by Application (2012-2017)

11 ILLINOIS DRUGS FOR SCHISTOSOMIASIS SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Drugs for Schistosomiasis Revenue, Sales and Growth Rate (2012-2017)
11.2 Illinois Drugs for Schistosomiasis Sales and Market Share by Type
11.3 Illinois Drugs for Schistosomiasis Sales by Application (2012-2017)

12 DRUGS FOR SCHISTOSOMIASIS MARKET FORECAST (2017-2022)

12.1 United States Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
12.2 Drugs for Schistosomiasis Market Forecast by States (2017-2022)
12.3 Drugs for Schistosomiasis Market Forecast by Type (2017-2022)
12.4 Drugs for Schistosomiasis Market Forecast by Application (2017-2022)

13 DRUGS FOR SCHISTOSOMIASIS MANUFACTURING COST ANALYSIS

13.1 Drugs for Schistosomiasis Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Drugs for Schistosomiasis

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Drugs for Schistosomiasis Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Analyst Introduction
17.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Drugs for Schistosomiasis Picture
Table Product Specifications of Drugs for Schistosomiasis
Figure United States Sales Market Share of Drugs for Schistosomiasis by Types in 2016
Table Types of Drugs for Schistosomiasis
Figure Praziquantel Picture
Table Major Manufacturers of Praziquantel
Figure Oxamniquine Picture
Table Major Manufacturers of Oxamniquine
Figure Other Picture
Table Major Manufacturers of Other
Table United States Drugs for Schistosomiasis Sales Market Share by Applications in 2016
Table Applications of Drugs for Schistosomiasis
Figure S. haematobium Picture
Figure S. mansoni Picture
Figure S. japonicum Picture
Figure S. mekongi Picture
Figure S. intercalatum Picture
Figure California Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Drugs for Schistosomiasis Revenue (Million USD) and Growth Rate (2012-2022)
Table Shin Poong Basic Information, Manufacturing Base and Competitors
Table Shin Poong Drugs for Schistosomiasis Type and Applications
Table Shin Poong Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Drugs for Schistosomiasis Type and Applications
Table Merck Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Drugs for Schistosomiasis Type and Applications
Table Bayer Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EIPICO Basic Information, Manufacturing Base and Competitors
Table EIPICO Drugs for Schistosomiasis Type and Applications
Table EIPICO Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Type and Applications
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taj Pharmaceuticals Drugs for Schistosomiasis Type and Applications
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Drugs for Schistosomiasis Sales by Manufacturer (2016-2017)
Figure United States Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2016
Figure United States Drugs for Schistosomiasis Sales Market Share by Manufacturer in 2017
Table United States Drugs for Schistosomiasis Revenue by Manufacturer (2016-2017)
Figure United States Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2015
Figure United States Drugs for Schistosomiasis Revenue Market Share by Manufacturer in 2016
Table United States Drugs for Schistosomiasis Price by Manufacturers (2016-2017)
Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2016
Figure Top 3 Drugs for Schistosomiasis Manufacturer Market Share in 2017
Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2016
Figure Top 5 Drugs for Schistosomiasis Manufacturer Market Share in 2017
Figure United States Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table United States Drugs for Schistosomiasis Sales by States (2012-2017)
Table United States Drugs for Schistosomiasis Sales Market Share by States (2012-2017)
Figure United States 2012 Drugs for Schistosomiasis Sales Market Share by States
Figure United States 2016 Drugs for Schistosomiasis Sales Market Share by States
Figure United States Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Table United States Drugs for Schistosomiasis Revenue by States (2012-2017)
Table United States Drugs for Schistosomiasis Revenue Market Share by States (2012-2017)
Table United States 2012 Drugs for Schistosomiasis Revenue Market Share by States
Table United States 2016 Drugs for Schistosomiasis Revenue Market Share by States
Table United States Drugs for Schistosomiasis Sales by Type (2012-2017)
Table United States Drugs for Schistosomiasis Sales Share by Type (2012-2017)
Table United States Drugs for Schistosomiasis Revenue by Type (2012-2017)
Table United States Drugs for Schistosomiasis Revenue Share by Type (2012-2017)
Figure United States Praziquantel Sales Growth (2012-2017)
Figure United States Praziquantel Price (2012-2017)
Figure United States Oxamniquine Sales Growth (2012-2017)
Figure United States Oxamniquine Price (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure United States Other Price (2012-2017)
Table United States Drugs for Schistosomiasis Sales by Application (2012-2017)
Table United States Drugs for Schistosomiasis Sales Share by Application (2012-2017)
Figure United States S. haematobium Sales Growth (2012-2017)
Figure United States S. mansoni Sales Growth (2012-2017)
Figure United States S. japonicum Sales Growth (2012-2017)
Figure United States S. mekongi Sales Growth (2012-2017)
Figure United States S. intercalatum Sales Growth (2012-2017)
Figure California Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure California Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table California Drugs for Schistosomiasis Sales by Type (2012-2017)
Table California Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table California Drugs for Schistosomiasis Sales by Application (2012-2017)
Table California Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure New York Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure New York Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table New York Drugs for Schistosomiasis Sales by Type (2012-2017)
Table New York Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table New York Drugs for Schistosomiasis Sales by Application (2012-2017)
Table New York Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure Texas Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Texas Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Texas Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Texas Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Texas Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Texas Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure Florida Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Florida Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Florida Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Florida Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Florida Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Florida Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure Illinois Drugs for Schistosomiasis Revenue and Growth (2012-2017)
Figure Illinois Drugs for Schistosomiasis Sales and Growth (2012-2017)
Table Illinois Drugs for Schistosomiasis Sales by Type (2012-2017)
Table Illinois Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Table Illinois Drugs for Schistosomiasis Sales by Application (2012-2017)
Table Illinois Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure United States Drugs for Schistosomiasis Sales, Revenue and Growth Rate (2017-2022)
Table United States Drugs for Schistosomiasis Sales Forecast by States (2017-2022)
Table United States Drugs for Schistosomiasis Market Share Forecast by States (2017-2022)
Table United States Drugs for Schistosomiasis Sales Forecast by Type (2017-2022)
Table United States Drugs for Schistosomiasis Market Share Forecast by Type (2017-2022)
Table United States Drugs for Schistosomiasis Sales Forecast by Application (2017-2022)
Table United States Drugs for Schistosomiasis Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Schistosomiasis
Figure Manufacturing Process Analysis of Drugs for Schistosomiasis
Figure Drugs for Schistosomiasis Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Schistosomiasis Major Manufacturers in 2016
Table Major Buyers of Drugs for Schistosomiasis
Table Distributors/Traders/ Dealers List